JCR Pharmaceuticals Co., Ltd.'s total assets for Q3 2025 were ¥105.52B, an increase of 0.86% from the previous quarter. JP:4552 total liabilities were ¥52.55B for the fiscal quarter, a 10.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.